These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1851896)

  • 21. Current aspects of research on the pathogenesis of diabetic neuropathy.
    Wuarin-Bierman L; Zahnd GR
    Diabete Metab; 1986 Dec; 12(6):319-24. PubMed ID: 3028879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus--present problems and new research. VI. Nephropathy and neuropathy.
    Sharkey TP
    J Am Diet Assoc; 1971 May; 58(5):442-4. PubMed ID: 4324852
    [No Abstract]   [Full Text] [Related]  

  • 23. ["Diabetic autonomic neuropathy" series. Epidemiology, pathogenesis, basic therapy and prognosis].
    Luft D
    MMW Fortschr Med; 2002 May; 144(20):47-50. PubMed ID: 12119885
    [No Abstract]   [Full Text] [Related]  

  • 24. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New theories of the pathogenesis of diabetic neuropathies].
    Lekishvili VP
    Klin Med (Mosk); 1974 Nov; 52(11):14-6. PubMed ID: 4373612
    [No Abstract]   [Full Text] [Related]  

  • 26. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
    N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.
    Greene DA; Lattimer SA; Sima AA
    N Engl J Med; 1987 Mar; 316(10):599-606. PubMed ID: 3027558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic peripheral neuropathy.
    Das AK; Vijayaraghavan MV
    J Assoc Physicians India; 1991 Oct; 39(10):760-3. PubMed ID: 1816202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contemporary views on the pathogenesis of diabetic neuropathy].
    Pierzchala K
    Wiad Lek; 1998; 51 Suppl 2():30-4. PubMed ID: 9686530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors and onset mechanisms of diabetic neuropathy].
    Hamada Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():209-14. PubMed ID: 12430231
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myo-inositol].
    Nakashima E; Nakamura J
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():456-62. PubMed ID: 12355790
    [No Abstract]   [Full Text] [Related]  

  • 33. [Metabolic disorder of polyol pathway].
    Hotta N
    Nihon Rinsho; 1997 Oct; 55 Suppl():745-51. PubMed ID: 9392191
    [No Abstract]   [Full Text] [Related]  

  • 34. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
    Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA
    Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of Ca2+ channels in the pathogenesis of diabetic neuropathy].
    Sanada M; Yasuda H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():647-51. PubMed ID: 15999785
    [No Abstract]   [Full Text] [Related]  

  • 36. [Metabolic factors in the pathogenesis of diabetic neuropathies].
    Hamada Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():504-8. PubMed ID: 15999760
    [No Abstract]   [Full Text] [Related]  

  • 37. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
    Malone JI; Lowitt S; Corsico N; Orfalian Z
    Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sorbitol pathway and the complications of diabetes.
    Gabbay KH
    N Engl J Med; 1973 Apr; 288(16):831-6. PubMed ID: 4266466
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathogenesis of diabetic neuropathy.
    N Engl J Med; 1989 Jan; 320(1):57-60. PubMed ID: 2909880
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diabetic neuropathy and the sorbitol cycle].
    Ide T
    Nihon Rinsho; 1969 Sep; 27(9):2350-4. PubMed ID: 5389229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.